# SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sglt2-inhibitors-and-mechanisms-of-cardiovascular-benefit-a-state-of-the-art/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Subodh Verma,John J.V. McMurray |
| Citations | 986 |
| DOI | 10.1007/s00125-018-4670-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00125-018-4670-7.pdf |
| OpenAlex ID | https://openalex.org/W2884466498 |
| PMID | 30132036 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Subodh Verma](https://scholariq.org/researchers/subodh-verma/)
- [John J.V. McMurray](https://scholariq.org/researchers/john-j-v-mcmurray/)

## Paper journal

- [Diabetologia](https://scholariq.org/journals/diabetologia/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.